[1]
Waiz, M. et al. 2022. Potential dual inhibitors of PCSK-9 and HMG-R from natural sources in cardiovascular risk management. EXCLI Journal. 21, (Jan. 2022), 47–76. DOI:https://doi.org/10.17179/excli2021-4453.